#weight-loss-drugs

[ follow ]
fromFuturism
1 month ago

Doctors Are Warning That Ozempic's Severe Side Effects May Outweigh Its Benefits

GLP-1 weight loss drugs like Ozempic and Wegovy have concerning side effects, including potential vision impairment and increased risk of kidney problems.
#ozempic
from24/7 Wall St.
3 months ago
Wearables

Novo Nordisk (NYSE: NVO) Stock Price Prediction and Forecast 2025-2030 (May 2025)

Ozempic's popularity is transforming Novo Nordisk into a major player in the obesity drug market.
The obesity drug market is expected to grow significantly, reaching $100 billion by 2030.
from24/7 Wall St.
4 months ago
Wearables

Novo Nordisk (NYSE: NVO) Stock Price Prediction and Forecast 2025-2030 (April 2025)

Ozempic's explosive sales growth reflects its successful transition from a diabetes treatment to a leading weight loss drug.
more#ozempic
fromBusiness Insider
1 month ago

The rise of Ozempic is a convenient excuse for retailers to cut back on plus-size options

It's difficult to envision a return to pre-pandemic levels of body positivity as brands continue to focus more on conventional beauty standards and thinness.
Fashion & style
Miscellaneous
fromBusiness Insider
1 month ago

Eli Lilly's 3-step strategy to dominate the $95 billion obesity market

Eli Lilly is becoming the leader in weight loss drugs, surpassing competitors like Novo Nordisk. Their drug portfolio is innovative and expansive.
fromwww.bbc.com
1 month ago

Weight loss jabs study begins after reports of pancreas issues

A study has been launched due to reports of serious side effects related to weight loss drugs potentially affecting the pancreas, prompting safety investigations.
Public health
fromNature
2 months ago

Obesity drugs show promise treating a new ailment: migraine

In a small study, the drug liraglutide reduced monthly migraine episodes by nearly half among people with obesity who experience the headache-inducing condition.
Alternative medicine
fromwww.theguardian.com
2 months ago

Weight loss drugs linked to higher risk of eye damage in diabetic patients

The study found that those who had been taking semaglutide or lixisenatide for at least six months had twice the risk of developing macular degeneration.
Alternative medicine
#novo-nordisk
Startup companies
fromFast Company
3 months ago

Novo Nordisk announces CEO transition as share price slips

Novo Nordisk's CEO Lars Fruergaard Jorgensen is stepping down amid market challenges despite leading the company through significant growth in the weight-loss drug sector.
Startup companies
fromFast Company
3 months ago

Novo Nordisk posts strong Q1 as weight-loss revolution claims another victim: WeightWatchers

Novo Nordisk's market outlook improves with FDA's ban on GLP-1 drug copycats.
Despite profit forecasts lowering, investor sentiment towards Novo Nordisk remains optimistic.
more#novo-nordisk
Alternative medicine
fromtime.com
3 months ago

Which Weight-Loss Drug Works the Best?

Zepbound shows superior weight loss compared to Wegovy in a recent clinical trial, influencing treatment decisions for obesity management.
Wearables
fromFuturism
3 months ago

Weight Watchers Goes Bankrupt After Rise of Ozempic-Like Drugs

Ozempic's popularity is reshaping the diet industry, severely affecting companies like Weight Watchers.
from24/7 Wall St.
3 months ago

Hims & Hers Shows It's More Than Just GLP-1 Drugs

Hims & Hers reported a remarkable 111% revenue increase to $586 million, driving its stock up 18%, alongside a 345% net income rise.
Growth hacking
fromwww.nytimes.com
4 months ago

Patients Cut Off From Cheaper Obesity Drugs as FDA Halts Sales of Copycats

FDA's crackdown on cheap weight-loss drugs threatens access for many Americans, raising treatment costs.
Compounded versions of Wegovy and Zepbound to be phased out as shortages are declared over.
[ Load more ]